Other causes of lung cancer are well known, like radon gas exposure, which happens to be fairly prevalent in Appalachia. It’s ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

The asset at play is fipaxalparant, a candidate designed to block the lysophosphatidic acid receptor 1 (LPAR1). Amgen tested ...

Thanks to advances in medicine, an Arkansas man was able to get diagnosed and overcome stage 4 lung cancer. Now, he's sharing ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

Engineers Design Lookalike Drug Carrier to Evade Lung's Lines of Defense Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new ...

TCGFB, a private biotech founded by healthcare VC The Column Group, is tapping California biotech Surrozen to discover ...

A new study by a team of 12 thoracic surgeons at Memorial Sloan Kettering Cancer Center (MSK), published recently in the ...

November is Lung Cancer Awareness Month, a time to raise awareness and share information surrounding the disease.

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

One such firm is working to treat cystic fibrosis - an inherited, life-threatening condition that can cause severe damage to ...

Verona Pharma has seen its share price skyrocket in anticipation of the commercial launch of its COPD treatment.